Candesic advises ARCHIMED on investment in Renata Medical
Paediatric medical device company Renata Medical has just closed a $25m Series D financing round. The round was led by global private equity investment firm ARCHIMED Candesic is delighted to have supported ARCHIMED with commercial due diligence on the investment in Renata, a US-based technology company focused on developing cardiovascular devices specifically for children with congenital heart disease. The Candesic…
Archimed taking Esperion private in $1.1bn deal
Pharmaceutical company Esperion Therapeutics has announced it has entered into a definitive agreement to be acquired by the healthcare focused investment firm Archimed in a $1.10bn deal. Esperion, a commercial-stage biopharma group dedicated to developing and delivering innovative cardiometabolic and rare/orphan disease therapies, has faced competitive pressures in the lipid lowering market and looking forward, will need to contend with…